UBP
OCUL icon

Union Bancaire Privee’s Ocular Therapeutix OCUL Stock Holding History

Union Bancaire Privee’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$160K Sell
20,000
-5,000
-20% -$45.3K ﹤0.01% 396
2026
Q1 		$148K Buy
25,000
+3,000
+14% +$28.6K ﹤0.01% 405
2025
Q4 		$212K Sell
22,000
-3,500
-14% -$42.5K ﹤0.01% 391
2025
Q3 		$255K Buy
+25,500
New +$305K ﹤0.01% 364

Other funds holding OCUL

DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
CC
Courier Capital Buffalo, New York $2B AUM 24.36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM

Union Bancaire Privee's OCUL Position: Q2 2026 in Review

Union Bancaire Privee reduced its Ocular Therapeutix (OCUL) stake by 20% in Q2 2026, selling an estimated $45.3K and leaving 20,000 shares worth $160K. The position accounts for ﹤0.01% of the portfolio, ranked #396.

Union Bancaire Privee first reported a position in OCUL in Q3 2025 and has held it in 4 quarters since. The position peaked at $255K in Q3 2025. 24 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

  • Union Bancaire Privee held 20,000 shares of Ocular Therapeutix worth $160K as of Q2 2026.
  • Union Bancaire Privee sold 5,000 Ocular Therapeutix shares in Q2 2026, an estimated $45.3K.
  • Ocular Therapeutix made up ﹤0.01% of Union Bancaire Privee's portfolio in Q2 2026, its #396 holding.
  • Union Bancaire Privee first reported a position in Ocular Therapeutix in Q3 2025 and has held it in 4 quarters since.
  • Union Bancaire Privee's Ocular Therapeutix position peaked at $255K in Q3 2025.
  • 24 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Union Bancaire Privee's 13F filing for Q2 2026, filed 16 Jul 2026.